Hidden Oral Inflammation and Biomarker Misclassification in Obstructive Sleep Apnea Trials

Clicks: 1
ID: 318232
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #7 of 39 articles by views in SLEEP Advances

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Inflammatory biomarkers are used as surrogate endpoints in obstructive sleep apnea (OSA) trials, assuming the measured signal originates from the airway or systemic response to intermittent hypoxia. Periodontitis – a common, extra-pulmonary inflammatory reservoir – elevates systemic active matrix metalloproteinase-8 (aMMP-8) independently of OSA. This Perspective examines whether unmeasured oral inflammation confounds biomarker attribution in OSA trials. Epidemiological and interventional evidence indicates that periodontitis is highly prevalent, is more common in individuals with OSA, and substantially elevates circulating aMMP-8. Moreover, non-surgical periodontal therapy reduces this signal to a degree comparable to early CPAP effects. In published CPAP trials that reported inflammatory or cardiovascular outcomes, periodontal status has not been reported or incorporated into primary analyses. We propose a heuristic conceptual model: measured circulating aMMP-8 = OSA-related component + periodontal-derived component + measurement noise. Without adjustment for periodontal status, observed changes cannot be uniquely attributed to OSA treatment. The ORBIT heuristic framework (Oral Reservoir Bias Inflammatory Trial) is introduced as a conceptual prompt for reporting oral inflammatory burden. Inflammatory biomarker responses in OSA trials are consistent with a composite signal that includes an unmeasured oral component. A testable prediction is that adjusting for periodontal status would reduce between-trial heterogeneity of MMP-8 effect estimates without altering within-subject respiratory outcomes. Prospective validation is warranted. The framework extends beyond aMMP-8 to any circulating inflammatory marker influenced by extra-target inflammatory reservoirs.
Reference Key
openalex_W7165523857 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Solomon O. Nwhator
Journal SLEEP Advances
Year 2026
DOI
10.1093/sleepadvances/zpag063
URL
https://doi.org/10.1093/sleepadvances/zpag063
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.